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Vibrio cholerae
SXT Element, Laos 
To the Editor: The SXT element
is a Vibrio cholerae–derived ICE
(integrating and conjugative element),
which has also been referred to as a
conjugative transposon (1) or a con-
stin (2). ICEs excise from the chromo-
somes of their hosts, transfer to a new
host through conjugation, and then
integrate into the chromosome again.
SXT element was originally isolated
in 1993 from a V. cholerae O139 clin-
ical isolate (SXTMO10) (1). The ≈100-
kbp SXT element confers resistance
to sulfamethoxazole, trimethoprim,
chloramphenicol, and streptomycin
(1). Since 1994, V. cholerae isolates
from Bangladesh, India, and
Mozambique have also contained the
SXT element (2–4). In SXTMO10,
resistance genes are embedded near
the 5′ end, in a ≈17.2-kbp composite
transposon-like element that inter-
rupts the SXT-encoded rumAB oper-
on. In contrast, in El Tor O1 V. choler-
ae strains isolated in India and
Bangladesh, the resistance genes are
located in SXTET, which is closely
related but not identical to SXTMO10
(2). Comparison of 2 related ICEs,
SXT of  V. cholerae and R391 of
Providencia rettgeri (5), showed that
the conserved backbone apparently
contains 3 hot spots for insertions of
additional DNA sequences: the first
between  sO43 and  traL, the second
between trA and sO54, and the third
between  sO73  and traF. R391 con-
tains an intact rumAB operon and a
transposon-associated kanamycin
resistance gene located ≈3.5 kbp from
the rumAB operon (6). Mobile genetic
elements such as SXT have a crucial
role in spreading antimicrobial drug
resistance genes among microbial
populations, and our understanding of
these genetic elements would help to
control the emergence of antimicro-
bial drug resistance. 
We have been monitoring the drug
sensitivity pattern in the Lao People’s
Democratic Republic (Laos) since
1993, and we have found that V.
cholerae O1 strains isolated after
1997 were resistant to tetracycline,
sulfamethoxazole, trimethoprim,
chloramphenicol, and streptomycin
(7). Analysis of the genetic determi-
nants encoding antimicrobial drug
resistance showed an SXT element
(SXTLAOS), which is different from
the previously reported SXTs (8).
SXTLAOS contains 2 novel open read-
ing frames (ORFs) in the third hot
spot (between sO73 and traF). SXTET
contains a class 9 integron in hot spot
sO73-traF that harbors dfrA1  as a
gene cassette (2). In SXTMO10, the
gene encoding trimethoprim resist-
ance (dfr18) is encoded in the ≈17.2-
kbp composite transposon-like ele-
ment that interrupts the SXT-encoded
rumAB operon. SXTLAOS does not
encode dfr18 or dfrA1, and the gene
encoding trimethoprim resistance has
not been identified. In this study, we
analyzed hot spot sO43-traL and hot
spot traA-sO54 to better characterize
SXTLAOS. 
Two sets of primers were designed
to amplify the hot spot regions.
Primer HS1-F, which anneals to
sO43, was 5′ GGC TAT TCC ACC
GGT GGT G 3′; primer HS1-R,
which anneals to traL, was 5′ TGC
CGA TCA CTA GCC CCA AC 3′;
primer HS2-F, which anneals to traA,
was 5′ ATG GGT CTC TAC AAT
ACG CC 3′; and primer HS2-R,
which anneals to sO54, was 5′ GGA
GAC AGC GCA AGC GCC AG 3′.
Polymerase chain reaction (PCR)
amplifications on genomic DNA
extracted from the V. cholerae O1
strain isolated in Laos (strain 00LA1)
with primers HS1-F and HS1-R
yielded an amplicon of ≈1100 bp,
which is slightly different from the
amplicon obtained with DNAextract-
ed from V. cholerae O139, strain
MO10 (≈1,000 bp). PCR amplifica-
tion using primers HS2-F and HS2-R
gave amplicons of similar size
(≈2,200 bp) for both strains. The
≈1,000-bp and ≈2,200-bp PCR prod-
ucts from strain 00LA1 were cloned
independently into the pCR 2.1 vec-
tor and tested to determine if recom-
binant plasmids confer trimethoprim
resistance after transformation to
Escherichia coli. No trimethoprim-
resistant colonies were observed after
transformation. The nucleotide
sequences of the inserted fragments
were analyzed. The region between
sO43 and traL showed 97% identity
to the corresponding region of P.
rettgeri  R391 (accession no.
AY090559), which encodes 2 hypo-
thetical proteins (ORF 37 and ORF
38). The region between traA and
sO54 showed 97% identity to the cor-
responding region of SXTMO10
(accession no. AY055428). Since the
gene encoding trimethoprim resist-
ance was not located in any of the hot
spot regions proposed by Beaber et
al. (5), we also analyzed the region
between  sO26 and  sO27, which in
R391 contains the kanamycin resist-
ance gene. Primers sO26-F (5′ GAG
CAA TGG GCG AGA GTT CC) and
s027-R (5′ TCA GCG ACA ACC
GGA GAA TG) gave an amplicon of
409 bp for SXTMO10, as expected,
while no PCR product was obtained
for SXTLAOS. This result suggested
that the region between sO26 and
sO27 in SXTLAOS is also different
from SXTMO10.
V. cholerae O139 has not been iso-
lated in Laos, and the SXT element
was not likely transmitted from a V.
cholerae O139 strain to a V. cholerae
O1 strain. Since SXTLAOS has a hot
spot that is identical to R391, we
show evidence for a possible inde-
pendent emerging of SXTLAOS.
Further analysis is needed to under-
stand the evolution and relationship
between different ICEs and the emer-
gence of new variants. 
In a previous study (8), we con-
firmed experimentally that trimetho-
prim resistance was also transferred
by conjugation, and we hypothesized
that the responsible gene is located
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within SXTLAOS. However, the gene
was not found in any of the proposed
hot spot regions. The possibility that
the trimethoprim resistance determi-
nant is located on the chromosome
outside the SXT element and cotrans-
fers with the SXT in an Hfr-like man-
ner cannot be ruled out (9). Therefore,
additional hot spot regions may exist
in SXT elements for insertion of
DNA; otherwise the trimethoprim
resistance gene is not encoded within
SXTLAOS.
The nucleotide sequence data
reported in this study will appear in
the DDBJ/EMBL/GenBank nucleo-
tide sequence databases with the
accession numbers AB185252 for the
hot spot sO43-traL and AB186353 for
the hot spot traA-sO54.
Claudia Toma,* Noboru Nakasone,*
Tianyan Song,* 
and Masaaki Iwanaga*
*University of the Ryukyus, Okinawa,
Japan
References 
1. Waldor MK, Tschäpe H, Mekalanos JJ. A
new type of conjugative transposon
encodes resistance to sulfamethoxazole,
trimethoprim, and streptomycin in Vibrio
cholerae O139. J Bacteriol. 1996;178:
4157–65.
2. Hochhut B, Lotfi Y, Mazel D, Faruque SM,
Woodgate R, Waldor MK. Molecular analy-
sis of antibiotic resistance gene clusters in
Vibrio cholerae O139 and O1 SXT con-
stins. Antimicrob Agents Chemother.
2001;45:2991–3000.
3. Amita, Chowdhury SR, Thungapathra M,
Ramamurthy T, Nair GB, Ghosh A. Class I
integrons and SXT elements in El Tor
strains isolated before and after 1992 Vibrio
cholerae O139 outbreak, Calcutta, India.
Emerg Infect Dis. 2003;9:500–2.
4.  Dalsgaard A, Forslund A, Sandvang D,
Arntzen L, Keddy K. Vibrio cholerae O1
outbreak in Mozambique and South Africa
in 1998 are multiple-drug resistant, contain
the SXT element and the aadA2 gene locat-
ed on class 1 integrons. J Antimicrob
Chemother. 2001;48:827–38.
5. Beaber JW, Burrus V, Hochhut B, Waldor
MK. Comparison of SXT and R391, two
conjugative integrating elements: definition
of a genetic backbone for the mobilization
of resistance determinants. Cell Mol Life
Sci. 2002;59:2065–70.
6. Böltner D, Mac Mahon C, Pembroke JT,
Strike P, Osborn A. R391: a conjugative
integrating mosaic comprised of phage,
plasmid, and transposon elements. J
Bacteriol. 2002;184:5158–69.
7. Phantouamath B, Sithivong N, Sisavath L,
Munnalath K, Khampheng C, Insisiengmay
S, et al. Transition of drug susceptibilities
of  Vibrio cholerae O1 in Lao People’s
Democratic Republic. Southeast Asian J
Trop Med Public Health. 2001;32:95–9.
8.  Iwanaga M, Toma C, Miyazato T,
Insisiengmay S, Nakasone N, Ehara M.
Antibiotic resistance conferred by a class I
integron and SXT constin in Vibrio choler-
ae strains isolated in Laos. Antimicrob
Agents Chemother. 2004;48:2364–9.
9.  Hochuut B, Marrero J, Waldor MK.
Mobilization of plasmids and chromosomal
DNA mediated by the SXT element, a con-
stin found in Vibrio cholerae O139. J
Bacteriol. 2000;182:2043–7.
Address for correspondence: Claudia Toma,
Division of Bacterial Pathogenesis, Department
of Microbiology, Graduate School of Medicine,
University of the Ryukyus, Nishihara, Okinawa
903-0215, Japan; fax: 81-98-895-1408; email:
k950417@med.u-ryukyu.ac.jp
Modeling the
Impact of
Pandemic Influenza
on Pacific Islands 
To the Editor: Many Pacific
Island countries and areas have been
severely impacted in influenza pan-
demics. The 1918 pandemic killed
substantial proportions of the total
population: Fiji ≈5.2%, Tonga ≈4.2%
to 8.4%, Guam ≈4.5%, Tahiti ≈10%,
and Western Samoa ≈19% to 22%
(1,2). Thirty-one influenza pandemics
have occurred since the first pandem-
ic in 1580 (3); another one is likely, if
not inevitable (4). The potential use of
influenza as a bioweapon is an addi-
tional concern (5). 
The scale of an influenza pandem-
ic may be projected on the basis of the
available historical data that have
been built into a computer model, e.g.,
FluAid (6). FluAid uses a determinis-
tic model to estimate the impact range
of an influenza pandemic in its first
wave. Given the lack of accessible
data for specific Pacific Island coun-
tries and areas, the default values used
in FluAid were used for the propor-
tion of the population in the high-risk
category for each age group, for the
death rates, hospitalizations, and ill-
ness requiring medical consultations.
Country-specific population data
were obtained from the Secretariat of
the Pacific Community, and hospital
bed data were obtained from the
World Health Organization (WHO)
(7,8). The FluAid model was supple-
mented by a model of an 8-week pan-
demic wave and modeling of hospital
bed capacity. Further methodologic
details are provided in the online
Appendix (available from htttp://
www.cdc.gov/ncidod/EID/vol11no02
/04-0951_app.htm).
The results indicate that at inci-
dence rates of 15% and 35%, pandem-
ic influenza would cause 650 and
1,530 deaths, respectively, giving
crude death rates of 22 to 52 per
100,000 (see the Table in the online
Appendix). Most deaths (83%) would
occur in the high-risk group, 60% of
whom would be 19–64 years of age,
and 22% would be ≥65 years of age.
Additionally, 3,540 to 8,250 persons
would be hospitalized, most of whom
(78%) would not have high-risk con-
ditions. Also, 241,000 to 563,000
medical consultations would occur.
Most (87%) consultations would be
for patients without high-risk condi-
tions (50% birth–18 years of age and
46% 19–64 years of age). 
In the peak week of the pandemic
(week 4), from 15% to 34% of all hos-
pital beds would be required for
patients with influenza (Table). The
upper end of impact on hospital beds
at  >40% would occur for Guam,